|
|
Treatment & Management
Summary
|
Phlebotomy Treatment
- Therapeutic phlebotomy is the preferred treatment for reducing iron
stores in hemochromatosis patients.
- For a patient who has no evident tissue or organ damage, proper
disease management may result in normal long-term outcome and life
expectancy.
Phlebotomy Regimen
- Clinicians must design phlebotomy treatment regimens that are
individualized to each patient and account for age, gender, weight,
health, and likelihood of compliance.
Monitoring Treatment
- Serum ferrinin levels should be measured after each additional one or
two phlebotomy treatments once the value is ≤ 100 ng/mL.
- Careful monitoring of each patient throughout treatment is imperative.
If treatment is too aggressive, anemia may result.
Lifetime Maintenance
- Continued lifetime monitoring is key to appropriate management.
- Phlebotomy should be performed throughout a patient’s life to keep the
serum ferritin level between 25 and 50 ng/mL.
Patient Compliance
This is an optional self-quiz and is not required for continuing
education credit.
Select the best answers below. If you need help, feel free to go back
to Phlebotomy Treatment,
Monitoring Treatment, or
Patient Compliance and review.
|
|